Results 81 to 90 of about 74,305 (343)
, 2015 Alopecia areata (AA) is a common, non-scarring alopecia that usually presents as well-circumscribed patches of sudden hair loss and affects 0.1-0.2% of the population. The aetiology of AA is thought to be both genetic and autoimmune in nature. One hundred and thirty-nine single nucleotide polymorphisms linked to AA have been identified in 8 regions of ...
Eshini Perera +2 more
openaire +3 more sources
Acta Dermato-VenereologicaOnline resources play a vital role in patient education, yet the readability of alopecia areata-related materials remained understudied. A thorough analysis of online alopecia areata-related materials across 5 languages was conducted using Google search.
Tomasz Skrzypczak +2 more
doaj +1 more source
А choice of therapy for severe forms of alopecia area [PDF]
Vestnik Dermatologii i VenerologiiAlopecia areata is a chronic organ-specific autoimmune inflammatory disease with a genetic predisposition. Alopecia areata is characterized by damage to hair follicles, persistent or temporary non-scarring hair loss.
Yulia A. Gallyamova
doaj +1 more source
Pili Annulati Coincident with Alopecia Areata, Autoimmune Thyroid Disease, and Primary IgA Deficiency: Case report and Considerations on the Literature [PDF]
, 2007 Pili annulati is a rare autosomal dominant hair disorder clinically characterized by a pattern of alternating bright and dark bands of the hair, the bright bands appearing dark if observed by transmitted light.
Caputo, V., Castelli, E., Fiorella, S.
core +3 more sources
Overview of Alopecia Areata [PDF]
Journal of Investigative Dermatology Symposium Proceedings, 2013 Alopecia areata is a complex genetic, immune-mediated disease that targets anagen hair follicles. The disease affects children and adults and is characterized by round or oval patches of hair loss, loss of all scalp hair (alopecia totalis), body hair (alopecia universalis), or ophiasis pattern hair loss.
openaire +3 more sources
JEADV Clinical Practice, EarlyView.ABSTRACT Alopecia areata (AA) and bullous pemphigoid (BP) are distinct autoimmune diseases, but growing evidence points to overlapping immune pathways. We present a rare case of a 71‐year‐old woman with concurrent AA and BP. She initially presented with 10 months of progressive scalp and body hair loss (Severity of Alopecia Tool [SALT] ~ 80) and nail ...
Anna Brinks +6 more
wiley +1 more source
Comparison of oral prednisolone pulse therapy with intravenous methylprednisolone pulse therapy in severe alopecia areata [PDF]
, 2013 Objective: To compare the efficacy of oral prednisolone pulse therapy in comparison to the intravenous methylprednisolone pulse therapy in treatment of severe alopecia areata. Patients and methods: In this interventional study, all patients with alopecia
Alborzi, A., Dehghan, A., Shahini, N.
core
Monitoring chemotherapy-induced alopecia with trichoscopy [PDF]
, 2018 Background: Chemotherapy-induced alopecia (CIA) ranks among the psychologically most devastating effects of cancer treatment for oncological patients, with an overall incidence of 65%. Nowadays trichoscopy is largely employed in the diagnosis of alopecia,
Cardone, Michele +6 more
core +1 more source
Indian Journal of Dermatology, Venereology and Leprology, 2021 BACKGROUND Tofacitinib and ruxolitinib have been used off-label to treat alopecia areata. Although a number of case reports and small studies have been published, there are no comprehensive reviews examining the outcomes of using tofacitinib and ...
Da-Ae Yu +3 more
semanticscholar +1 more source
BMJ, 2010 #### Summary points Alopecia areata is a common condition characterised by sudden onset of patchy hair loss without signs of skin inflammation or scarring. It accounts for about 2% of new referrals for dermatology in the UK and United States and has an estimated lifetime risk of 1.7%.1 Data from the National Health and Nutrition Examination Survey ...
Ralf Paus +4 more
openaire +3 more sources